Search
for
Sort by
Research 811–840 of 1000+
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Jak inhibitors in the treatment of alopecia areata - a literature review
- JAK inhibitors and alopecia areata
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- JAK Inhibitors in the Treatment of Lichen Planopilaris
- Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- 570 Targeting JAK/STAT and Wnt/b-catenin pathways and 5a-reductase activity to develop an effective anti-hair loss product
- 865 Conditional ablation of JAK-STAT5 signaling induces anagen hair growth
- 700 Oncostatin M is upstream of JAK-STAT signaling during the murine hair cycle
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK Inhibitors in Down Syndrome: Alopecia Areata Resolution and Vitiligo Improvement with Baricitinib
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- 706 Predictive modeling of patient response to JAK/STAT inhibitors and dynamic patient-matching
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- Tofacitinib in the Management of Alopecia Universalis
- 75360 Nasal hair (vibrissae) involvement in patients with alopecia areata universalis: preliminary results showing density modification and response to oral JAK inhibitors
- Poster Presentations
- Molecular Mechanisms of Hair Follicle Development
- Targeted immunotherapy for hair regrowth and regeneration
- 73192 Consistent Efficacy of Upadacitinib in Alopecia Areata Subgroups: Adult, Pediatric, Severe Disease, and JAK-Refractory Patients — A Meta-Analysis
- CECHY ZASTOSOWANIA FIZJOTERAPII WRODZONEGO KRĘCZU SZYI